A Study to Assess the Safety, Tolerability and How Single Ascending Doses of ABBV-859 Moves Through the Body of Healthy Adult Participants

NCT07736638 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
64
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AbbVie